IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $8,572,000 | -9.7% | 422,261 | -28.3% | 1.31% | -5.2% |
Q2 2017 | $9,488,000 | +40.4% | 589,311 | +10.3% | 1.38% | +28.3% |
Q1 2017 | $6,759,000 | +2.2% | 534,311 | +7.0% | 1.08% | -13.6% |
Q4 2016 | $6,614,000 | -9.6% | 499,153 | +21.8% | 1.24% | -2.9% |
Q3 2016 | $7,318,000 | +8.5% | 409,964 | +75.2% | 1.28% | +0.1% |
Q2 2016 | $6,742,000 | – | 233,934 | – | 1.28% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NORTH TIDE CAPITAL, LLC | 3,000,000 | $37,950,000 | 5.83% |
Healthcare Value Capital, LLC | 200,000 | $2,530,000 | 4.33% |
Ratan Capital Management LP | 354,400 | $4,483,000 | 2.15% |
SECTOR GAMMA AS | 534,311 | $6,759,000 | 1.08% |
Sivik Global Healthcare LLC | 168,030 | $2,126,000 | 0.99% |
Schonfeld Strategic Advisors LLC | 547,157 | $6,922,000 | 0.69% |
Iguana Healthcare Management, LLC | 100,000 | $1,265,000 | 0.63% |
Century Capital Management, LLC | 250,716 | $3,172,000 | 0.50% |
Fosun International Ltd | 300,000 | $3,795,000 | 0.47% |
Atika Capital Management LLC | 39,500 | $499,000 | 0.24% |